Clinical Trials Directory

Trials / Completed

CompletedNCT05233917

Effects of Olive Oil and MLCT on Glycolipid Homeostasis in Patients With Metabolic Syndrome

The Precision Nutritional Management for MetS (PNMM)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
240 (actual)
Sponsor
Zhejiang University · Academic / Other
Sex
All
Age
40 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The type of cooking oil used is a crucial factor influencing dietary quality. The purpose of this study is to investigate the effects of olive oil and MLCT oil intervention on glucose and lipid homeostasis in patients with MetS.

Detailed description

We conducted a 6-month RCT to evaluate the effects of olive oil and MLCT as cooking oils on glucose and lipid homeostasis in patients with MetS; investigate the changes in lipoprotein subfractions and metabolites using NMR spectroscopy, alongside gut microbiota alterations, to elucidate potential mechanisms; and identify baseline variables associated with the anti-obesity effects of olive oil and MLCT.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTOlive oil useOlive oil, 25-30g/d by day for 6 month
DIETARY_SUPPLEMENTMLCT oil useMLCT oil, 25-30g/d by day for 6 month

Timeline

Start date
2023-06-09
Primary completion
2023-12-09
Completion
2023-12-22
First posted
2022-02-10
Last updated
2024-11-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05233917. Inclusion in this directory is not an endorsement.

Effects of Olive Oil and MLCT on Glycolipid Homeostasis in Patients With Metabolic Syndrome (NCT05233917) · Clinical Trials Directory